Impact of Changes of Components of the Risk Score on Future Prevalence of Diabetes with the Institute for Biometry and Epidemiology German Diabetes Center

NOTICE OF INTENT TO SOLE SOURCE:

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to the Institute for Biometry and Epidemiology German Diabetes Center for an Impact of changes of components of the risk score on future prevalence of diabetes.  This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government.  A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government.  Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.  Any quotation/response should be emailed to contract specialist at ycf1l@cdc.gov by 1:00 p.m. on June 15, 2021.